Every 424B that Algorhythm Holdings Inc (RIME) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RIME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RIME filings page.
Algorhythm Holdings, Inc. is registering up to 10,000,000 shares of common stock for resale by Streeterville Capital, LLC. These shares may be issued to Streeterville under prepaid purchase agreements between the parties. The offering is a resale by the selling stockholder; the company will receive no proceeds from sales by Streeterville.
The prospectus states there were 15,425,958 shares outstanding as of the date of this prospectus. Streeterville previously purchased shares by exercising its purchase rights (12,077,557 shares issued to date). Aggregate obligations owed to Streeterville total $21,285,000, with approximately $701,000 outstanding under the first Pre-Paid Purchase and $10,355,000 outstanding under the fourth Pre-Paid Purchase. Streeterville is limited to beneficial ownership of 9.99% and resale plans must comply with Nasdaq Listing Rule 5635(d).
Algorhythm Holdings (RIME) filed a prospectus to offer up to 1,133,652 shares of common stock issuable upon exercise of outstanding Series A warrants. The warrants have a cash exercise price of $8.38 per share, are currently exercisable, and expire on January 13, 2030. In the event all Series A warrants are exercised for cash, the company would receive approximately $9,500,000 in proceeds.
Shares outstanding were 2,641,778 as of September 29, 2025. Assuming full exercise of the Series A warrants, shares outstanding would be 3,775,430. The company’s common stock trades on Nasdaq as “RIME,” and the last reported sale price was $2.048 per share on November 7, 2025. The prospectus highlights risks including potential dilution from warrant exercises and going concern uncertainty noted in the auditor’s report for the year ended December 31, 2024.
Algorhythm Holdings, Inc. (RIME) filed a prospectus to register the resale of up to 10,095,694 shares of common stock by Streeterville Capital, LLC. The registered shares include 95,694 commitment shares already issued and up to 10,000,000 additional shares that may be issued under a pre‑paid purchase facility. The company will not receive any proceeds from Streeterville’s resale of these shares.
Under the Securities Purchase Agreement, Algorhythm may conduct one or more pre‑paid purchases for an aggregate purchase price of up to $20,000,000. Streeterville may, at its discretion, acquire shares against outstanding balances at a purchase price equal to 90% of the lowest 10‑day VWAP, subject to a floor price defined as the greater of 20% of the Nasdaq “Minimum Price” or $0.10, a 9.99% beneficial ownership cap, and Nasdaq Listing Rule 5635(d) limits unless shareholder approval is obtained. The plan of distribution permits sales via brokers, private transactions, or dealer transactions.
Shares outstanding were 2,641,778 as of September 29, 2025; the table shows up to 12,641,778 shares outstanding after the offering. The prospectus highlights risks including potential dilution and selling pressure from resales, and discloses prior losses and an auditor’s going‑concern explanatory paragraph for the year ended December 31, 2024.